RxDoctor Payments Data

James Gast, MD

Family Medicine · Green Bay, WINPI 1710961529

Payments from drug & device makers

$380in general payments, 2019–2025

Across 20 payments — averaging $18.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$98
  • E.r. Squibb & Sons, L.L.C.$61
  • Johnson & Johnson$41
  • AstraZeneca$37
  • Boehringer Ingelheim$27
  • Teva Pharmaceuticals USA, Inc.$25
  • plus $90 from 6 others

What the payments were for

  • Food & beverage$31884%
  • Education$6116%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$380 in reported general payments places this provider in the 75th percentile of 1,482 family medicine providers in Wisconsin.

See all family medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$365,413
Medicare patients
3,746
Services billed
25,724

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban92$119,884
JardianceEmpagliflozin95$117,191
JanuviaSitagliptin Phosphate23$28,993
OzempicSemaglutide23$28,471
FarxigaDapagliflozin Propanediol22$27,628
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$21,323
TrulicityDulaglutide12$20,710
Bydureon BciseExenatide Microspheres17$20,013
XareltoRivaroxaban12$15,526
Spiriva HandihalerTiotropium Bromide11$13,702
Breo ElliptaFluticasone/Vilanterol21$12,376
Nicotrol NsNicotine13$9,184
Lantus SolostarInsulin Glargine,hum.Rec.Anlog53$7,456
Fluticasone-SalmeterolFluticasone Propion/Salmeterol30$6,470
Atorvastatin Calcium629$6,142

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$19$119,88492 claims
Boehringer IngelheimJardiance$27$117,19195 claims
AstraZenecaFarxiga$37$27,62822 claims
Johnson & JohnsonXarelto$41$15,52612 claims
Teva Pharmaceuticals USA, Inc.Qvar Redihaler$25$3,43611 claims
AbbVieSynthroid$16$2,24733 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,482 family medicine providers in Wisconsin.

Other family medicine in Green Bay

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →